Deepgenomics
Toronto, CA · Founded 2014 · 6 known investors
Deep Genomics develops an AI platform for drug discovery and development, applying machine learning to genomic data to design RNA therapeutics. The company runs its AI platform and preclinical research from Toronto, with clinical and business development teams based in Boston.
AI & Machine LearningBiotechHealthtech
Founders & leadership
Deepgenomics was founded in 2014 by Brendan Frey.
BF
Brendan FreyChief Innovation Officer and Founder
BO
Brian O'CallaghanChief Executive Officer
DJ
David JohnstonChief Financial Officer
CB
Clive BertramChief Business Officer
TM
Tom MastersonChief Operating Officer
GH
Greg HoffmanChief Scientific Officer
Investors · 6
Founder mafia
2 people who came through Deepgenomics went on to found or lead other companies.
Competitors · 4
by search overlapGenomeweb22 shared keywordsGenomeWeb's Research Funding section publishes news coverage of research grants and government funding trends in genetics, genomics, and molecular diagnostics. It is an industry news publication serving researchers and organizations in the life sciences.
Oup17 shared keywordsOxford University Press publishes research, educational, and reference materials, including reports on reading and children's learning, and reference resources such as its dictionary "Word of the Day." It serves readers, educators, and learners across a wide range of subjects worldwide.
Genomics Plc14 shared keywordsGenomics builds a genotype-phenotype database and genetic risk-prediction tools used to support pharmaceutical drug discovery and clinical trials, as well as population health management and clinical decision support for healthcare providers. It serves life sciences companies and healthcare systems through its Life Sciences and Health & Wellness divisions.
10x Genomics 1-color13 shared keywords10x Genomics offers single cell analysis technology, including its Flex assay and Flex Apex product, which use probe-based chemistry and plate-based multiplexing to profile fresh, frozen, and FFPE samples for researchers. The tools support applications in cancer, immunology, and neuroscience, enabling gene expression and multiomic profiling of cell surface protein, intracellular protein, and CRISPR guides.
Companies competing with Deepgenomics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Deepgenomics do?
- Deep Genomics develops an AI platform for drug discovery and development, applying machine learning to genomic data to design RNA therapeutics. The company runs its AI platform and preclinical research from Toronto, with clinical and business development teams based in Boston.
- Who founded Deepgenomics?
- Deepgenomics was founded by Brendan Frey in 2014.
- Who are Deepgenomics's investors?
- Deepgenomics's investors include 11.2 Capital, Future Ventures, Kensington Capital Partners Limited, Magnetic Ventures, SoftBank Vision Fund, Bloomberg Beta.
- Where is Deepgenomics headquartered?
- Deepgenomics is headquartered in Toronto, CA.